![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Accelerated Approval for IgA Nephropathy Treatment (CheckRare) View |
![]() |
Accelerated Approval for Atrasentan in IgAN (Nephrology Times) View |
![]() |
Understanding Atrasentan (Vanrafia) for IgA Nephropathy, with Richard Lafayette, MD (HCPLive) View |
![]() |
Clinical Trial: Sparsentan for Treatment of IgA Nephropathy (CheckRare) View |
![]() |
VANRAFIA - FDA NDA approval - 2025-04-02 (Inside Drug Discovery) View |
![]() |
Efficacy of Atrasentan To Treat Patients With IgA Nephropathy (CheckRare) View |
![]() |
FDA Approves BREAKTHROUGH KIDNEY Medicine To Save Millions of People (Katherine) View |
![]() |
Rare Diseases Update by LucidQuest Episode 13 (LucidQuest) View |
![]() |
Rare Disease Updates: IgG4-RD, PKU, IgAN, LCA5 u0026 More (LucidQuest) View |
![]() |
Calliditas Therapeutics delivers on sales after approval of its Lead Drug (Pareto Securities AB) View |